Daily News Service
RSS Feed
WIF helps commercialization of research
Friday, June 4, 2010
Three Western researchers have been recognized with Western Innovation Fund (WIF) awards to help bringing their work out of the lab and closer to commercialization.
The awards,
launched in 2004 and distributed annually by the Office of the Vice-President
(Research & International Relations), provide incentive for researchers to
explore commercial opportunities outside the lab.
With funding totaling
$110,000 for the successful January 2010 competition applicants, the following
projects are on their road to commercialization:
• Jesse Zhu,
Particle Technology Research Centre / Chemical & Biochemical Engineering
Co-applicant/Collaborator: George Nakhla, Chemical &
Biochemical/Civil & Environmental Engineering
Award: $50,000
Title: Prototype Compact and Mobile Bioreactor for Wastewater Treatment
This project is
based on a synergistic collaboration and complementation of expertise in
wastewater treatment, biochemical engineering and fluidized bed technology, and
will lead to a very practical technique to treat wastewater in isolated or
remote areas.
A novel CFBBR
(Circulating Fluidized Bed Bioreactor) technology has been developed, offering
numerous advantages in wastewater treatment. This new technology is 8-10 times
more efficient than the conventional activated sludge wastewater treatment
process and 3-5 times more efficient than those advanced technologies under
development or just implemented for commercial use in recent years.
This new process
also saves half of the capital cost and land use. This WIF award will allow set
up and testing of a new version of this CFBBR, which should lead to rapid commercialization
of this technology.
• Heinz-Bernhard
Kraatz, Chemistry, Science
Award: $48,000
Title: Development of a test for HIV reverse transcriptase
HIV (human immunodeficiency virus) is a virus that attacks the immune system, making it difficult for the body to fight off infection and diseases.
HIV (human immunodeficiency virus) is a virus that attacks the immune system, making it difficult for the body to fight off infection and diseases.
The current diagnosis of HIV infection involves the use of antibody tests that rely on the presence of viral
antibodies present in blood, essentially making it impossible to detect very
recent HIV infections by conventional antibody testing.
The proposed WIF project is building on our detection platform for the
detection of proteins, and focuses
on the development and optimization of
a working prototype device for the detection of HIV enzymes.
•
Susan
Scollie, School of Communication Sciences and
Disorders, Health Sciences
Co-applicant/Collaborator: William Hodgetts, Speech Pathology and
Audiology, Rehabilitation Medicine, University of Alberta
Award: $12,000
Title: Application of the DSL v.5.0a DLL to bone-anchored hearing aid prescription
This project
proposes to adapt the DSL v. 5.0a DLL, a Western-developed technology, for use
in bone-anchored hearing aid (Baha) prescription. The Desired Sensation
Level (DSL) Method is a hearing aid prescription that calculates the required
amplification of hearing aids.
This ensures amplified speech is audible,
comfortable and safe for infants, children, and adults.
The DSL v5.0 has
been adopted by the majority of large hearing aid companies as part of their
software for programming digital hearing aid technology.
In this project, Scollie
will adapt the DSL v5.0 prescription for use in bone-anchored hearing aids. These
surgically implanted devices transmit sound by direct conduction through bone
to the inner ear, bypassing the external auditory canal and middle ear.
Also from this web page:
About
Hours
Weekdays
8:30 a.m. to 5 p.m.
(holidays excluded)
Contact
Publisher:
Helen Connell (hconnell@uwo.ca)
Editor:
Jason Winders (newseditor@uwo.ca)
Reporter/Photographer:
Paul Mayne (pmayne@uwo.ca)
Reporter/Photographer:
Heather Travis (htravis2@uwo.ca)
Advertising Coordinator:
Denise Jones (advertise@uwo.ca)
Off-Campus Advertising Sales:
Chris Amyot, Campus Ad (campusad@sympatico.ca)
National Advertising Representative:
Campus Plus
Phone:
519-661-2045
Fax:
519-661-3921
Mail:
Western News, Suite 360
Westminster Hall
The University of Western Ontario, London N6A 3K7
Western
provides the best student experience among Canada's leading research-intensive
universities.



